Stem cell therapy for incontinence: Where are we now? What is the realistic potential?

Current Urology Reports

Volumn 12, Issue 5, 2011, Pages 336-344

  Dissaranan, Charuspong ^a   Cruz, Michelle A ^a   Couri, Bruna M ^a   Goldman, Howard B ^a   Damaser, Margot S ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

ADCSCs; Adipose derived stem cells; BMSCs; Bone marrow derived stem cells; Gynecology; HUCBs; Human umbilical cord blood cells; Incontinence; MDSCs; Muscle derived stem cells; Noninvasive therapy; Regenerative; Stem cell; Stress urinary incontinence; Voiding dysfunction; Women's health

Indexed keywords

ADIPOSE DERIVED STEM CELL; ADIPOSE DERIVED STEM CELL TRANSPLANATION; ARTICLE; BONE MARROW TRANSPLANTATION; CORD BLOOD STEM CELL TRANSPLANTATION; EMBRYONIC STEM CELL; EMBRYONIC STEM CELL TRANSPLANATION; HEMATOPOIETIC STEM CELL; HUMAN; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MUSCLE DERIVED STEM CELL; MUSCLE TRANSPLANTATION; NONHUMAN; STEM CELL; STEM CELL RESEARCH; STEM CELL TRANSPLANTATION; STRESS INCONTINENCE;

ADIPOCYTES; FEMALE; HUMANS; MYOBLASTS; STEM CELL TRANSPLANTATION; URINARY INCONTINENCE, STRESS;

EID: 80755143249     PISSN: 15272737     EISSN: 15346285     Source Type: Journal    
DOI: 10.1007/s11934-011-0210-4     Document Type: Article

References (93)

1. S Charalambous A Trantafylidis 2009 Impact of urinary incontinence on quality of life Pelviperineology 28 2 51 53
2. I Milsom 2009 Lower urinary tract symptoms in women Curr Opin Urol 19 4 337 341 19444118 10.1097/MOU.0b013e32832b659d
3. CG Nilsson K Palva M Rezapour C Falconer 2008 Eleven years prospective follow-up of the tension-free vaginal tape procedure for treatment of stress urinary incontinence Int Urogynecol J 19 8 1043 1047 10.1007/s00192-008-0666-z 1:STN:280:DC%2BD1cvltFKguw%3D%3D
4. AL Olsen VJ Smith JO Bergstrom JC Colling AL Clark 1997 Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence Obstet Gynecol 89 501 506 9083302 10.1016/S0029-7844(97)00058-6 1:STN:280:DyaK2s3js1KjtA%3D%3D (Pubitemid 27133519)
5. RG Rogers 2010 What's best in the treatment of stress urinary incontinece? New Engl J Med 362 22 2124 2125 20479458 10.1056/NEJMe1005367 1:CAS:528:DC%2BC3cXntVCiu74%3D
6. ME Albo HE Richter L Brubaker P Norton SR Kraus PE Zimmern, et al. 2007 Burch colposuspension versus fascial sling to reduce urinary stress incontinence New Engl J Med 356 21 2143 2155 17517855 10.1056/NEJMoa070416 1:CAS:528:DC%2BD2sXlvVersLY%3D (Pubitemid 47010840)
7. K Gungorduk I Celebi C Ark O Celikkol G Yildirim 2009 Which type of mid-urethral sling procedure should be chosen for treatment of stress urinary incontinance with intrinsic sphincter deficiency? tension-free vaginal tape or transobturator tape Acta Obstet Gynecol Scand 88 8 920 926 19565366 10.1080/00016340903100354
8. A Staack LV Rodriguez 2011 Stem cells for the treatment of urinary incontinence Curr Urol Rep 12 1 41 46 21113694 10.1007/s11934-010-0155-z
9. H Oshima TR Payne KL Urish T Sakai YQ Ling B Gharaibeh, et al. 2005 Differential myocardial infarct repair with muscle stem cells compared to myoblasts Mol Ther 12 6 1130 1141 16125468 10.1016/j.ymthe.2005.07.686 1:CAS:528:DC%2BD2MXht1GhsbzK (Pubitemid 41723047)
10. Q Fu XF Song GL Liao CL Deng L Cui 2010 Myoblasts differentiated from adipose-derived stem cells to treat stress urinary incontinence Urology 75 3 718 723 19969332 10.1016/j.urology.2009.10.003
11. AC Drost S Weng G Feil J Schafer S Baumann L Kanz, et al. 2009 In vitro myogenic differentiation of human bone marrow-derived mesenchymal stem cells as a potential treatment for urethral sphincter muscle repair Hematopoietic Stem Cells Vii 1176 135 143 1:CAS:528:DC%2BD1MXhtlKqt7bF
12. GZ Wu X Zheng ZQ Jiang JH Wang YF Song 2010 Induced differentiation of adipose-derived stromal cells into myoblasts J Huazhong Univ Sci Technol Med Sci 30 3 285 290 20556569 10.1007/s11596-010-0344-5
13. S Herschorn L Carr C Birch M Murphy M Robert R Jankowski, et al. 2010 Autologous muscle-derived cells as therapy for stress urinary incontinence: a randomized, blinded trial Neurourol Urodyn 29 2 307
14. XL Tang G Rokosh SK Sanganalmath Y Pang FP Yuan SJ Dai, et al. 2008 Beneficial effects of cardiac progenitor cells on LV function 1 year after treatment in rats with myocardial infarction Circulation 118 18 S289 S290
15. LC Amado KH Schuleri AP Saliaris AJ Boyle R Helm B Oskouei, et al. 2006 Multimodality noninvasive imaging demonstrates in vivo cardiac regeneration after mesenchymal stem cell therapy J Am Coll Cardiol 48 10 2116 2124 17113001 10.1016/j.jacc.2006.06.073 (Pubitemid 44738440)
16. MA Kuliszewski J Kobulnik JR Lindner DJ Stewart H Leong-Poi 2011 Vascular gene transfer of SDF-1 promotes endothelial progenitor cell engraftment and enhances angiogenesis in ischemic muscle Mol Ther 19 5 895 902 21364544 10.1038/mt.2011.18 1:CAS:528:DC%2BC3MXisFKksrc%3D
17. •• Sundararaman S, Miller TJ, Pastore JM, Kiedrowski M, Aras R, Penn MS. Plasmid-based transient human stromal cell-derived factor-1 gene transfer improves cardiac function in chronic heart failure. Gene Ther. 2011. In this paper, the authors demonstrate that increasing expression of stromal cell-derived factor-1 promoted angiogenesis and improved cardiac function in rats with ischemic heart failure, presumably by attracting stem cells to the region to facilitate recovery from the injury. These data demonstrate that stand-alone nonviral gene transfer is a strategy for improving cardiac function, and could possibly work for the lower urinary tract as well.
18. C Gandia A Arminan JM Garcia-Verdugo E Lledo A Ruiz MD Minana, et al. 2008 Human dental pulp stem cells improve left ventricular function, induce angiogenesis, and reduce infarct size in rats with acute myocardial infarction Stem Cells 26 3 638 645 18079433 10.1634/stemcells.2007-0484
19. N Nagaya T Fujii T Iwase H Ohgushi T Itoh M Uematsu, et al. 2004 Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis Am J Physiol Heart Circ Physiol 287 6 H2670 H2676 15284059 10.1152/ajpheart.01071. 2003 1:CAS:528:DC%2BD2cXhtVOmurbJ (Pubitemid 39557139)
20. XL Tang G Rokosh YR Guo R Bolli 2010 Cardiac progenitor cells and bone marrow-derived very small embryonic-like stem cells for cardiac repair after myocardial infarction Circ J 74 3 390 404 20081317 10.1253/circj.CJ-09-0923
21. SM Hashemi S Ghods FD Kolodgie K Parcham-Azad M Keane D Hamamdzic, et al. 2008 A placebo controlled, dose-ranging, safety study of allogenic mesenchymal stem cells injected by endomyocardial delivery after an acute myocardial infarction Eur Hear J 29 2 251 259 10.1093/eurheartj/ehm559
22. M Gnecchi HM He OD Liang LG Melo F Morello H Mu, et al. 2005 Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells Nat Med 11 4 367 368 15812508 10.1038/nm0405-367 1:CAS:528:DC%2BD2MXivFChurc%3D (Pubitemid 40562318)
23. R Uemura M Xu N Ahmad M Ashraf 2006 Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling Circ Res 98 11 1414 1421 16690882 10.1161/01.RES.0000225952.61196.39 1:CAS:528: DC%2BD28XltFWqtro%3D (Pubitemid 43948066)
24. M Gnecchi ZP Zhang AG Ni VJ Dzau 2008 Paracrine mechanisms in adult stem cell signaling and therapy Circ Res 103 11 1204 1219 19028920 10.1161/CIRCRESAHA.108.176826 1:CAS:528:DC%2BD1cXhtlKrt7bF
25. JM Hare JH Traverse TD Henry N Dib RK Strumpf SP Schulman, et al. 2009 A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction J Am Coll Cardiol 54 24 2277 2286 19958962 10.1016/j.jacc.2009.06.055 1:CAS:528:DC%2BC3cXmsl2guw%3D%3D The authors report results that demonstrate that intravenous allogeneic human mesenchymal stem cells are safe to administer to patients with myocardial infarction. This clinical study provides pivotal safety and provisional efficacy data for allogeneic BMSCs in postinfarction patients and suggests this approach could be useful in therapy for other conditions
26. S Janssens C Dubois J Bogaert K Theunissen C Deroose W Desmet, et al. 2006 Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial Lancet 367 9505 113 121 16413875 10.1016/S0140-6736(05)67861-0 (Pubitemid 43077127)
27. B Assmus A Rolf S Erbs A Elsasser W Haberbosch R Hambrecht, et al. 2010 Clinical outcome 2 years after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction Circ Heart Fail 3 1 89 96 19996415 10.1161/CIRCHEARTFAILURE.108.843243
28. J Bartunek S Dimmeler H Drexler F Fernandez-Aviles M Galinanes S Janssens, et al. 2006 The consensus of the task force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for repair of the heart Eur Hear J 27 11 1338 1340 10.1093/eurheartj/ehi793 (Pubitemid 43998109)
29. JH Traverse TD Henry DE Vaughn SG Ellis CJ Pepine JT Willerson, et al. 2009 Rationale and design for TIME: a phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction Am Hear J 158 3 356 363 10.1016/j.ahj.2009.06.009
30. JH Traverse TD Henry DE Vaughan SG Ellis CJ Pepine JT Willerson, et al. 2010 LateTIME a phase-ii, randomized, double-blinded, placebo-controlled, pilot trial evaluating the safety and effect of administration of bone marrow mononuclear cells 2 to 3 weeks after acute myocardial infarction Tex Hear Inst J 37 4 412 420
31. SJ Morrison AC Spradling 2008 Stem cells and niches: mechanisms that promote stem cell maintenance throughout life Cell 132 4 598 611 18295578 10.1016/j.cell.2008.01.038 1:CAS:528:DC%2BD1cXivVagtrs%3D (Pubitemid 351253690)
32. AA Shokeir AM Harraz ABS El-Din 2010 Tissue engineering and stem cells: basic principles and applications in urology Int J Urol 17 12 964 973 20969644 10.1111/j.1442-2042.2010.02643.x 1:CAS:528:DC%2BC3MXltleqsg%3D%3D
33. LDS Meirelles PC Chagastelles NB Nardi 2006 Mesenchymal stem cells reside in virtually all post-natal organs and tissues J Cell Sci 119 11 2204 2213 10.1242/jcs.02932 1:CAS:528:DC%2BD28Xms1Gisr4%3D (Pubitemid 43960310)
34. RH Lee B Kim I Choi H Kim HS Choi K Suh, et al. 2004 Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue Cell Physiol Biochem 14 4-6 311 324 15319535 10.1159/000080341 1:CAS:528:DC%2BD2cXmslOmsrc%3D (Pubitemid 39179200)
35. S Kern H Eichler J Stoeve H Kluter K Bieback 2006 Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue Stem Cells 24 5 1294 1301 16410387 10.1634/stemcells.2005-0342 1:CAS:528:DC%2BD28XhtFGhu7fJ (Pubitemid 44464698)
36. P De Coppi D Delo L Farrugia K Udompanyanan JJ Yoo M Nomi, et al. 2005 Angiogenic gene-modified muscle cells for enhancement of tissue formation Tissue Eng 11 7-8 1034 1044 16144439 10.1089/ten.2005.11.1034 (Pubitemid 41321406)
37. DS Goodsell 2003 The molecular perspective: VEGF and angiogenesis Stem Cells 21 1 118 119 12529559 10.1634/stemcells.21-1-118 (Pubitemid 36120373)
38. DJ Prockop CA Gregory JL Spees 2003 One strategy for cell and gene therapy: harnessing the power of adult stem cells to repair tissues Proc Natl Acad Sci U S A 100 11917 11923 13679583 10.1073/pnas.1834138100 1:CAS:528:DC%2BD3sXotFSmtbs%3D (Pubitemid 37205904)
39. LR Zhao WM Duan M Reyes CD Keene CM Verfaillie WC Low 2002 Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats Exp Neurol 174 1 11 20 11869029 10.1006/exnr.2001.7853 (Pubitemid 34218904)
40. HK Salem C Thiemermann 2010 Mesenchymal stromal cells: current understanding and clinical status Stem Cells 28 3 585 596 19967788 1:CAS:528:DC%2BC3cXlvVGlur0%3D
41. LC Amado AP Saliaris KH Schuleri M St John JS Xie S Cattaneo, et al. 2005 Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction Proc Natl Acad Sci U S A 102 32 11474 11479 16061805 10.1073/pnas.0504388102 1:CAS:528:DC%2BD2MXoslKiur0%3D (Pubitemid 41153844)
42. M Sasaki R Abe Y Fujita S Ando D Inokuma H Shimizu 2008 Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type J Immunol 180 4 2581 2587 18250469 1:CAS:528:DC%2BD1cXhsVSgs7o%3D
43. JS Duffield JV Bonventre 2005 Kidney tubular epithelium is restored without replacement with bone marrow-derived cells during repair after ischemic injury Kidney Int 68 5 1956 1961 16221175 10.1111/j.1523-1755.2005.00629.x 1:CAS:528:DC%2BD2MXht1SgtbjK (Pubitemid 43117771)
44. A Shabbir D Zisa G Suzuki T Lee 2009 Heart failure therapy mediated by the trophic activities of bone marrow mesenchymal stem cells: a noninvasive therapeutic regimen Am J Physiol Heart Circ Physiol 296 6 H1888 H1897 19395555 10.1152/ajpheart.00186.2009 1:CAS:528:DC%2BD1MXnsF2lt7k%3D The authors demonstrated that intramuscularly injected mesenchymal stem cells (MSCs) and MSC-conditioned medium each significantly improved ventricular function in a hamster heart failure model, suggesting that cell therapy does not need to be local to be effective. Because multiple tissues are damaged during delivery, this suggests that a less invasive approach could be utilized to deliver a cell-based therapy
45. C Dissaranan B Gill M Cruz L Salcedo B Brian M Kiedrowski, et al. 2011 Intravenous mesenchymal stem cells facilitate recovery from stress urinary incontinence after childbirth injury Neurourol Urodyn 30 2 235
46. LL Woo A Hijaz M Kuang MS Penn MS Damaser RR Rackley 2007 Overexpression of stem cell homing cytokines in rat pelvic organs following vaginal distension J Urol 177 1568 1572 17382780 10.1016/j.juro.2006.11.047 1:CAS:528: DC%2BD2sXksVantb8%3D (Pubitemid 46436016)
47. HM Wood M Kuang L Woo A Hijaz RS Butler M Penn, et al. 2008 Cytokine expression after vaginal distention of different durations in virgin Sprague-Dawley rats J Urol 180 2 753 759 18554634 10.1016/j.juro.2008.03.182 1:CAS:528:DC%2BD1cXpsFyiu7Y%3D
48. H Strasser S Berjukow R Marksteiner E Margreiter S Hering G Bartsch, et al. 2004 Stem cell therapy for urinary stress incontinence Exp Gerontol 39 9 1259 1265 15489048 10.1016/j.exger.2004.07.003 (Pubitemid 39360366)
49. RP Lanza HY Chung JJ Yoo PJ Wettstein C Blackwell N Borson, et al. 2002 Generation of histocompatible tissues using nuclear transplantation Nat Biotechnol 20 7 689 696 12089553 10.1038/nbt703 1:CAS:528:DC%2BD38XkvVGls74%3D (Pubitemid 34734135)
50. WW Minuth L Sorokin K Schumacher 2004 Generation of renal tubules at the interface of an artificial interstitium Cell Physiol Biochem 14 4-6 387 394 15319542 10.1159/000080348 1:CAS:528:DC%2BD2cXmslOms7g%3D (Pubitemid 39179207)
51. Geijsen N, Horoschak M, Kim K, Gribnau J, Eggan K, Daley GQ. In vitro generation of male germ cells from embryonic stem cells. Biol Reprod. 2004;87
52. Y Toyooka N Tsunekawa R Akasu T Noce 2003 Embryonic stem cells can form germ cells in vitro Proc Natl Acad Sci U S A 100 20 11457 11462 14504407 10.1073/pnas.1932826100 1:CAS:528:DC%2BD3sXotFKmsb4%3D (Pubitemid 37205957)
53. SA Przyborski 2005 Differentiation of human embryonic stem cells after transplantation in immune-deficient mice Stem Cells 23 9 1242 1250 16210408 10.1634/stemcells.2005-0014 (Pubitemid 41504912)
54. KK Jain 2005 Ethical and regulatory aspects of embryonic stem cell research Expert Opin Biol Ther 5 2 153 162 15757377 10.1517/14712598.5.2.153 1:STN:280:DC%2BD2M7islSitw%3D%3D (Pubitemid 40388845)
55. MF Pittenger AM Mackay SC Beck RK Jaiswal R Douglas JD Mosca, et al. 1999 Multilineage potential of adult human mesenchymal stem cells Science 284 5411 143 147 10102814 10.1126/science.284.5411.143 1:CAS:528:DyaK1MXitlCnu7o%3D (Pubitemid 29282067)
56. B Delorme P Charbord 2007 Culture and characterization of human bone marrow mesenchymal stem cells Tissue Eng Meth Mol Med 140 67 81 1:CAS:528:DC%2BD2sXhtVSnt7%2FF
57. D Nikolavsky MB Chancellor 2010 Stem cell therapy for stress urinary incontinence Neurourol Urodyn 29 S36 S41 20419800 10.1002/nau.20833
58. A Furuta RJ Jankowski R Pruchnic S Egawa N Yoshimura MB Chancellor 2008 Physiological effects of human muscle-derived stem cell implantation on urethral smooth muscle function Int Urogynecol J 19 9 1229 1234 10.1007/s00192-008-0608- 9
59. SO Kim HS Na D Kwon SY Joo HS Kim Y Ahn 2011 Bone-marrow-derived mesenchymal stem cell transplantation enhances closing pressure and leak point pressure in a female urinary incontinence rat model Urol Int 86 1 110 116 20689260 10.1159/000317322 The authors demonstrated that allogenic MSCs can increase LPP in a rat model of SUI, providing preliminary data for clinical trials in this area
60. J Corcos G Ghoniem C Comiter OL Westney S Herschorn 2010 Durability of macroplastioue (R) injection for female stress urinary incontinence: 2 years experience Neurourol Urodyn 29 2 275
61. Y Kinebuchi N Aizawa T Imamura O Ishizuka Y Igawa O Nishizawa 2010 Autologous bone-marrow-derived mesenchymal stem cell transplantation into injured rat urethral sphincter Int J Urol 17 4 359 368 20202003 10.1111/j.1442-2042.2010.02471.x The authors treated rats that had undergone urethrolysis and periuethral cardiotoxin injection with autologous BMSCs. They found that the proportions of skeletal muscle cells and peripheral nerves in the urethra were significantly greater in the BMSC group compared to the control group, suggesting that stem cells can facilitate reinnervation of the urethra after a denervation injury
62. XH Zou YL Zhi X Chen HM Jin LL Wang YZ Jiang, et al. 2010 Mesenchymal stem cell seeded knitted silk sling for the treatment of stress urinary incontinence Biomaterials 31 18 4872 4879 20303586 10.1016/j.biomaterials.2010. 02.056 1:CAS:528:DC%2BC3cXkvVaqtb4%3D The authors developed a tissue-engineered sling with bone marrow-derived mesenchymal stem cell-seeded degradable silk scaffold. They found that both the silk sling and tissue-engineered sling showed convincing functional effects for the treatment of SUI in a rat model. The better ligament-like tissue formation in the tissue-engineered sling suggested the potential for improved long-term function with less failure
63. A Usas J Huard 2007 Muscle-derived stem cells for tissue engineering and regenerative therapy Biomaterials 28 36 5401 5406 17915311 10.1016/j. biomaterials.2007.09.008 1:CAS:528:DC%2BD2sXht1WqtbnJ (Pubitemid 47599647)
64. Li Y. Isolating stem cells from soft musculoskeletal tissues. J Vis Exp. 2010;5(41)
65. ZQ Qu L Balkir JCT van Deutekom PD Robbins R Pruchnic J Huard 1998 Development of approaches to improve cell survival in myoblast transfer therapy J Cell Biol 142 5 1257 1267 9732286 10.1083/jcb.142.5.1257 1:CAS:528: DyaK1cXlvFejur0%3D (Pubitemid 28429107)
66. XY Wu SL Wang BL Chen XL An 2010 Muscle-derived stem cells: isolation, characterization, differentiation, and application in cell and gene therapy Cell Tissue Res 340 3 549 567 20495827 10.1007/s00441-010-0978-4
67. BM Deasy RJ Jankowski J Huard 2001 Muscle-derived stem cells: characterization and potential for cell-mediated therapy Blood Cell Mol Dis 27 5 924 933 10.1006/bcmd.2001.0463 1:STN:280:DC%2BD38%2FlslelsQ%3D%3D (Pubitemid 33145039)
68. D Kwon Y Kim R Pruchnic R Jankowski I Usiene F De Miguel, et al. 2006 Periurethral cellular injection: comparison of muscle-derived progenitor cells and fibroblasts with regard to efficacy and tissue contractility in an animal model of stress urinary incontinence Urology 68 2 449 454 16904482 10.1016/j.urology.2006.03.040 (Pubitemid 44175517)
69. JY Lee SY Paik SH Yuk JH Lee SH Ghil SS Lee 2004 Long term effects of muscle-derived stem cells on leak point pressure and closing pressure in rats with transected pudendal nerves Mol Cell 18 3 309 313 1:CAS:528: DC%2BD2MXpsFartg%3D%3D (Pubitemid 40298025)
70. Y Xu Y Song 2009 Transplantation of muscle-derived stem cell plus fibrin glue restores urethral function in a pudendal nerve-transected rat model Neurourol Urodyn 28 7 822 823
71. MB Chancellor T Yokoyama S Tirney CE Mattes H Ozawa N Yoshimura, et al. 2000 Preliminary results of myoblast injection into the urethra and bladder wall: a possible method for the treatment of stress urinary incontinence and impaired detrusor contractility Neurourol Urodyn 19 3 279 287 10797585 10.1002/(SICI)1520-6777(2000)19:3<279::AID-NAU9>3.0.CO;2-M 1:STN:280:DC%2BD3c3lvFyltQ%3D%3D (Pubitemid 30253985)
72. AM Kajbafzadeh A Elmi S Payabvash AH Salmasi P Saeedi A Mohamadkhani, et al. 2008 Transurethral autologous myoblast injection for treatment of urinary incontinence in children with classic bladder exstrophy J Urol 180 3 1098 1105 18639289 10.1016/j.juro.2008.05.057
73. H Strasser R Marksteiner E Margreiter M Mitterberger GM Pinggera F Frauscher, et al. 2007 Transurethral ultrasonography-guided injection of adult autologous stem cells versus transurethral endoscopic injection of collagen in treatment of urinary incontinence World J Urol 25 4 385 392 17701044 10.1007/s00345-007-0190-7 1:STN:280:DC%2BD2svovFentg%3D%3D
74. S Kleinert R Horton 2008 Retraction-autologous myoblasts and fibroblasts for treatment of stress urinary incontinence: a randomised controlled trial Lancet 372 9641 789 790 18774408 10.1016/S0140-6736(08)61320-3
75. LK Carr D Steele S Steele D Wagner R Pruchnic R Jankowski, et al. 2008 1-year follow-up of autologous muscle-derived stem cell injection pilot study to treat stress urinary incontinence Int Urogynecol J 19 6 881 883 10.1007/s00192-007-0553-z 1:STN:280:DC%2BD1crpslWiuw%3D%3D (Pubitemid 351597572)
76. K Peters M Kaufman R Dmochowski L Carr S Hershorn M Fischer, et al. 2011 Autologous muscle derived cell therapy for the treatment of female stress urinary incontinence: a multi-center experience J Urol 185 4 e535 e536 10.1016/j.juro.2011.02.1161
77. R Roche F Festy X Fritel 2010 Stem cells for stress urinary incontinence: the adipose promise J Cell Mol Med 14 1-2 135 142 19799652 10.1111/j.1582-4934. 2009.00915.x
78. LV Rodriguez Z Alfonso R Zhang J Leung B Wu LJ Ignarro 2006 Clonogenic multipotent stem cells in human adipose tissue differentiate into functional smooth muscle cells Proc Natl Acad Sci U S A 103 32 12167 12172 16880387 10.1073/pnas.0604850103 1:CAS:528:DC%2BD28XotlymtLw%3D (Pubitemid 44215829)
79. GT Lin GF Wang L Banie HX Ning AW Shindel TM Fandel, et al. 2010 Treatment of stress urinary incontinence with adipose tissue-derived stem cells Cytotherapy 12 1 88 95 19878076 10.3109/14653240903350265 1:CAS:528: DC%2BC3cXovVGjsQ%3D%3D The authors investigated whether transplantation of ADSCs can treat SUI in a rat model. They found that ADSC-treated groups had significantly higher elastin content than the control group, and within the ADSC-treated groups, rats with normal voiding pattern also had significantly higher elastin content than rats with voiding dysfunction. This suggests that proper elastin repair is important to restoration of function in treating SUI
80. W Zhao C Zhang C Jin Z Zhang L Kong W Xu, et al. 2011 Periurethral injection of autologous adipose-derived stem cells with controlled-release nerve growth factor for the treatment of stress urinary incontinence in a rat model Eur Urol 59 1 155 163 21050657 10.1016/j.eururo.2010.10.038 1:CAS:528: DC%2BC3cXhsV2js7%2FJ The authors investigated if nerve growth factor facilitated the effect of ADSCs delivered periurethrally. They found significant improvements in LPP as well as in the amount of muscle and ganglia in the group that received nerve growth factor, suggesting that this and other growth factors could be utilized to facilitate recovery from SUI
81. P Menasch O Alfieri S Janssens W McKenna H Reichenspurner L Trinquart, et al. 2008 The myoblast autologous grafting in ischemic cardiomyopathy (MAGIC) trial-first randomized placebo-controlled study of myoblast transplantation Circulation 117 9 1189 1200 10.1161/CIRCULATIONAHA.107.734103 (Pubitemid 351552018)
82. T Yamamoto M Gotoh R Hattori K Toriyama Y Kamei H Iwaguro, et al. 2010 Periurethral injection of autologous adipose-derived stem cells for the treatment of stress urinary incontinence in patients undergoing radical prostatectomy: report of two initial cases (Retracted article. See vol. 17, pg. 896, 2010) Int J Urol 17 1 75 82 20002225 10.1111/j.1442-2042.2009.02429.x
83. J Rehman D Traktuev JL Li S Merfeld-Clauss CJ Temm-Grove JE Bovenkerk, et al. 2004 Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells Circulation 109 10 1292 1298 14993122 10.1161/01.CIR.0000121425. 42966.F1 (Pubitemid 38372789)
84. Retraction. Periurethral injection of autologous adipose-derived stem cells for the treatment of stress urinary incontinence in patients undergoing radical prostatectomy: report of two initial cases. Int J Urol. 2010;17(10):896
85. A Flynn F Barry T O'Brien 2007 UC blood-derived mesenchyrnal stromal cells: an overview Cytotherapy 9 8 717 726 17917891 10.1080/14653240701584578 1:CAS:528:DC%2BD2sXhtl2is7jK (Pubitemid 350226750)
86. VD Roobrouck F Ulloa-Montoya CM Verfaillie 2008 Self-renewal and differentiation capacity of young and aged stem cells Exp Cell Res 314 9 1937 1944 18439579 10.1016/j.yexcr.2008.03.006 1:CAS:528:DC%2BD1cXlslOrurY%3D
87. JY Kim HB Jeon YS Jang W Oh JW Jhang 2010 Application of human umbilical cord blood-derived mesenchymal stem cells in disease models World J Stem Cells 2 2 34 38 21607114 10.4252/wjsc.v2.i2.34
88. JJ Lim JB Jang JY Kim SH Moon CN Lee KJ Lee 2010 Human umbilical cord blood mononuclear cell transplantation in rats with intrinsic sphincter deficiency J Kor Med Sci 25 5 663 670 10.3346/jkms.2010.25.5.663
89. CN Lee JB Jang JY Kim C Koh JY Baek KJ Lee 2010 Human cord blood stem cell therapy for treatment of stress urinary incontinence J Kor Med Sci 25 6 813 816 10.3346/jkms.2010.25.6.813
90. CAB Jahoda CJ Whitehouse AJ Reynolds N Hole 2003 Hair follicle dermal cells differentiate into adipogenic and osteogenic lineages Exp Dermatol 12 6 849 859 14714566 10.1111/j.0906-6705.2003.00161.x (Pubitemid 38028676)
91. RM Lavker TT Sun H Oshima Y Barrandon M Akiyama C Ferraris, et al. 2003 Hair follicle stem cells J Investig Dermatol Symp Proc 8 1 28 38 12894992 10.1046/j.1523-1747.2003.12169.x (Pubitemid 36900488)
92. T Drewa R Joachimiak A Kaznica V Sarafian J Sir 2009 Primary cultures from rat vibrissae as a potential cell source for in vitro construction of urinary bladder wall grafts Transplant Proc 41 5 1932 1935 19545759 10.1016/j.transproceed.2009.02.091 1:CAS:528:DC%2BD1MXnsV2ru74%3D
93. YY Zhang E McNeill H Tian S Soker KE Andersson JJ Yoo, et al. 2008 Urine derived cells are a potential source for urological tissue reconstruction J Urol 180 5 2226 2233 18804817 10.1016/j.juro.2008.07.023 1:CAS:528: DC%2BD1cXhtlWqs73K